Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
20,711 total articles
XORTX Therapeutics Inc. has terminated its investor relations agreement with IR Agency LLC and returned the previously paid marketing fees, opting to postpone its investor relations program while completing its voluntary delisting from the TSX Venture Exchange. The company aims to reduce regulatory complexity and focus on advancing its pharmaceutic…
MoneyHero Limited, a Nasdaq-listed fintech company specializing in AI-powered personal finance aggregation and digital insurance brokerage in Greater Southeast Asia, announced it will release its Q2 2026 results on September 11, 2026, before market open and host a conference call. The firm operates across Singapore, Hong Kong, Taiwan, and the Phili…
Teva Pharmaceutical Industries Ltd. has announced a proposed acquisition of the novel dexmedetomidine sublingual film product, BXCL501, from BioXcel Therapeutics through a court-supervised sale process. The product is under FDA review for at-home treatment of agitation in adults with schizophrenia or bipolar disorder, potentially becoming the first…
Netcapital Inc. announced that it received a notification from Nasdaq for failing to timely file its Annual Report on Form 10-K for the fiscal year ended April 30, 2026. The company has 60 days to submit a plan to regain compliance and could be granted up to 180 days to file the report if Nasdaq accepts the plan. There is uncertainty whether the co…
Immuron Limited reported preliminary financial results for FY26, exceeding sales and profit projections with record A$7.7 million sales, driven by growth in Australia and the U.S. The company achieved key clinical milestones including FDA IND approval for IMM-529 and U.S. Department of Defense-funded research collaborations. Immuron plans to invest…
Quoin Pharmaceuticals announced a private placement financing to raise up to $50 million, including upfront funding of approximately $30.8 million, aimed at supporting the completion of clinical development programs for rare and orphan disease therapies, particularly for Netherton Syndrome. The proceeds are expected to fund operations through mid-2…
Jiayin Group Inc., a fintech platform listed on NASDAQ, reported a sharp decline in its Q2 2026 financial performance with a 74.4% drop in transaction volume to RMB9.5 billion and a net loss of RMB183.6 million compared to net income of RMB519.1 million in the same period last year. The company is transitioning its strategy from scale-driven growth…
Quoin Pharmaceuticals announced positive interim results from its ongoing Phase 2/3 study evaluating QRX003 4% lotion in patients with Netherton Syndrome. The study showed that 66.7% of the first six patients achieved a significant improvement in skin condition after 12 weeks of treatment, meeting the trial's primary endpoint with statistical signi…
BioXcel Therapeutics announced its entry into a court-supervised Chapter 11 bankruptcy process and an asset sale agreement with Teva Pharmaceuticals, which will act as the stalking horse bidder for the company's assets, including its drug IGALMI®. The company secured $19 million in DIP financing to support ongoing operations during the bankruptcy p…
Cytokinetics announced positive top-line results from its ACACIA-HCM Phase 3 trial evaluating aficamten in symptomatic non-obstructive hypertrophic cardiomyopathy (nHCM). The trial met dual primary endpoints showing statistically significant improvements in patient-reported outcomes and exercise capacity compared to placebo. Based on these results,…
CDT Equity Inc. announced validation of new solid drug forms with improved physical properties such as stability and solubility, secured by patents in their intellectual property portfolio. These innovations enable tailored formulations for underserved patient groups and extend the commercial life of existing assets. By integrating AI-driven data a…
GCL Global Holdings Ltd., a Nasdaq-listed gaming and entertainment company, announced a board-approved $10 million share buyback program to repurchase ordinary shares over the next 12 months. This action reflects management's confidence in the company's long-term growth prospects and financial strength, particularly focusing on the expanding Asian …
Heartflow, Inc. announced late-breaking one-year results from the FUSION trial demonstrating that their AI-driven Heartflow FFRCT Analysis reduces unnecessary invasive coronary catheterizations by 44%, improving diagnostic efficiency without compromising patient safety. Funded by the Dutch National Health Care Institute, the independent randomized …
Micware Co., Ltd. finalized its group reorganization effective September 1, 2026, consolidating its location-based services into Micware Spacia and strengthening its in-vehicle software platforms through Micware Automotive and Micware Mobility. This restructuring aims to optimize promotion structures for its DynaPlanet and micAuto-PF platform busin…
HUTCHMED announces that China's NMPA has conditionally approved ATLED® (fanregratinib), a selective FGFR1/2/3 inhibitor, for adult patients with advanced or metastatic intrahepatic cholangiocarcinoma (ICC) harboring FGFR2 fusions/rearrangements after prior systemic therapy. The approval is based on strong Phase II clinical data showing significant …
Inflection Point Acquisition Corp. VIII, a special purpose acquisition company (SPAC), has priced its initial public offering of 25 million units at $10 per unit, raising $250 million. The units will trade on Nasdaq under the ticker IPHXU starting August 28, 2026. The SPAC plans to pursue mergers or acquisitions primarily with North American or Eur…
FinVolution Group, a leading fintech platform listed on NYSE, announced its Q2 2026 unaudited financial results. The company saw a sequential increase in net revenue and net profit after earlier risk mitigation actions, driven by resilient performances in both Chinese Mainland and overseas markets despite declines in transaction volume and profit c…
Healthy Choice Wellness Corp. (NYSE American: HCWC), a natural and organic grocery sector holding company, declared a 1-for-35 reverse stock split effective August 28, 2026. The split aims to elevate the stock price to comply with NYSE American's minimum $4.00 share price requirement following an anticipated merger with Host Digital Infrastructure …
Koss Corporation announced its financial results for Q4 and fiscal year ended June 30, 2026, showing a 5.8% increase in Q4 net sales and a net income turnaround to $476,801 from a net loss the previous year. Fiscal year sales grew 3.1%, aided by custom headphones sales to the education sector and strong domestic direct-to-consumer and distributor s…
McEwen Inc., via its majority-owned subsidiary McEwen Copper, has completed a $240 million senior secured term loan to fund engineering and early works at the Los Azules copper project, aiming for a final investment decision by mid-2027 and commercial production by 2030. The financing demonstrates confidence in the project and Argentina's improving…
NVIDIA has announced it will present at the Goldman Sachs Communacopia + Technology Conference on September 10, 2026, offering the financial community an update. The presentation will be webcast live and available for replay for 90 days.
Hooker Furnishings Corporation announced that it will present its fiscal 2027 second quarter financial results on September 11, 2026, via teleconference and live webcast. The company, with a 102-year history, designs, markets, and manufactures a broad range of residential, hospitality, and contract furniture across various premium and upper-medium …
LeMaitre Vascular, a provider of vascular devices for treating peripheral vascular disease, announced that its CFO, Dorian LeBlanc, will participate in three upcoming investor conferences in September 2026. This includes events hosted by Wells Fargo, Morgan Stanley, and Barrington Research. The company aims to engage with investors and provide upda…
Capital Southwest Corporation, a Nasdaq-listed business development company specializing in middle market financing, announced a quarterly regular dividend of $0.58 per share and a supplemental dividend of $0.06 per share for the quarter ending December 31, 2026. The regular dividend will be paid monthly in October, November, and December, with the…
Alamos Gold Inc. has declared a quarterly dividend of US$0.04 per common share, continuing its tradition of paying dividends for 17 consecutive years. The company has returned $106 million to shareholders in 2026 through dividends and share buybacks. The dividend is payable on September 24, 2026, to shareholders of record on September 10, 2026. A d…
